Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 11 to 20 of 31

Publication Record

Connections

Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases.
Wicherts DA, de Haas RJ, Sebagh M, Saenz Corrales E, Gorden DL, Lévi F, Paule B, Azoulay D, Castaing D, Adam R
(2011) Br J Surg 98: 399-407
MeSH Terms: Adult, Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Bilirubin, Colorectal Neoplasms, Female, Hepatectomy, Humans, Liver Neoplasms, Male, Middle Aged, Preoperative Care, Prothrombin, Recovery of Function
Added May 9, 2014
1 Communities
1 Members
0 Resources
19 MeSH Terms
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
Kozloff MF, Berlin J, Flynn PJ, Kabbinavar F, Ashby M, Dong W, Sing AP, Grothey A
(2010) Oncology 78: 329-39
MeSH Terms: Adult, Aged, Aged, 80 and over, Alkaline Phosphatase, Angiogenesis Inhibitors, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Bevacizumab, Cohort Studies, Colorectal Neoplasms, Diabetes Complications, Disease-Free Survival, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged, Neoplasm Metastasis, Proportional Hazards Models, Survival Analysis, Thromboembolism, Time Factors, Treatment Outcome
Added March 20, 2014
0 Communities
1 Members
0 Resources
24 MeSH Terms
Antiangiogenic therapies in early-stage breast cancer.
Derleth C, Mayer IA
(2010) Clin Breast Cancer 10 Suppl 1: E23-31
MeSH Terms: Angiogenesis Inhibitors, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Breast Neoplasms, Chemotherapy, Adjuvant, Female, Humans, Neoadjuvant Therapy, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor A
Added March 23, 2014
0 Communities
1 Members
0 Resources
12 MeSH Terms
Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.
Chung CH, Seeley EH, Roder H, Grigorieva J, Tsypin M, Roder J, Burtness BA, Argiris A, Forastiere AA, Gilbert J, Murphy B, Caprioli RM, Carbone DP, Cohen EE
(2010) Cancer Epidemiol Biomarkers Prev 19: 358-65
MeSH Terms: Adenocarcinoma, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Bevacizumab, Biomarkers, Tumor, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Cetuximab, Colorectal Neoplasms, ErbB Receptors, Erlotinib Hydrochloride, Gefitinib, Head and Neck Neoplasms, Humans, Kaplan-Meier Estimate, Lung Neoplasms, Mass Spectrometry, Mutation, Protein Kinase Inhibitors, Proteomics, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), Quinazolines, Signal Transduction, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, ras Proteins
Added March 5, 2014
0 Communities
3 Members
0 Resources
27 MeSH Terms
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study.
Kozloff M, Yood MU, Berlin J, Flynn PJ, Kabbinavar FF, Purdie DM, Ashby MA, Dong W, Sugrue MM, Grothey A, Investigators of the BRiTE study
(2009) Oncologist 14: 862-70
MeSH Terms: Adolescent, Adult, Aged, Angiogenesis Inhibitors, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Cohort Studies, Colorectal Neoplasms, Disease Progression, Disease-Free Survival, Female, Hemorrhage, Humans, Hypertension, Intestinal Perforation, Male, Middle Aged, Neoplasm Metastasis, Randomized Controlled Trials as Topic, Thromboembolism, Treatment Outcome, Young Adult
Added March 20, 2014
0 Communities
1 Members
0 Resources
24 MeSH Terms
Chemotherapy and immunotherapy in metastatic colorectal cancer.
Pohlmann PR, Mernaugh RL, Goff LW
(2009) N Engl J Med 360: 2134; author reply 2135-6
MeSH Terms: Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Capecitabine, Cetuximab, Colorectal Neoplasms, Deoxycytidine, Disease-Free Survival, Drug Monitoring, Fluorouracil, Humans, Neoplasm Metastasis, Organoplatinum Compounds, Oxaliplatin, Proto-Oncogene Proteins, Proto-Oncogene Proteins p21(ras), ras Proteins
Added March 11, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.
Salmon S, Chen H, Chen S, Herbst R, Tsao A, Tran H, Sandler A, Billheimer D, Shyr Y, Lee JW, Massion P, Brahmer J, Schiller J, Carbone D, Dang TP
(2009) J Thorac Oncol 4: 689-96
MeSH Terms: Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Bevacizumab, Biomarkers, Tumor, Carcinoma, Non-Small-Cell Lung, Case-Control Studies, Cohort Studies, Erlotinib Hydrochloride, Female, Humans, Lung Neoplasms, Male, Middle Aged, Neoplasm Recurrence, Local, Pleural Effusion, Malignant, Prognosis, Quinazolines, Reproducibility of Results, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Survival Rate, Treatment Outcome
Added March 10, 2014
0 Communities
2 Members
0 Resources
25 MeSH Terms
Angiogenesis in the treatment of non-small cell lung cancer.
Horn L, Sandler AB
(2009) Proc Am Thorac Soc 6: 206-17
MeSH Terms: Angiogenesis Inhibitors, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Bevacizumab, Carcinoma, Non-Small-Cell Lung, Clinical Trials as Topic, Drug Therapy, Combination, Humans, Lung Neoplasms, Neovascularization, Pathologic, Vascular Endothelial Growth Factor A
Added June 26, 2014
0 Communities
1 Members
0 Resources
11 MeSH Terms
Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinoma.
Cho DC, Puzanov I, Regan MM, Schwarzberg T, Seery V, Lee MY, Liu V, Bhatt R, Koon H, Mier JW, Sosman JA, Atkins MB, McDermott DF
(2009) J Immunother 32: 181-5
MeSH Terms: Angiogenesis Inhibitors, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Benzenesulfonates, Bevacizumab, Carcinoma, Renal Cell, Female, Heart Diseases, Humans, Indoles, Interleukin-2, Kidney Neoplasms, Male, Middle Aged, Niacinamide, Phenylurea Compounds, Pyridines, Pyrroles, Retrospective Studies, Salvage Therapy, Sorafenib, Sunitinib, Vascular Endothelial Growth Factor A
Added March 20, 2014
0 Communities
1 Members
0 Resources
24 MeSH Terms
Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
Rini BI, Michaelson MD, Rosenberg JE, Bukowski RM, Sosman JA, Stadler WM, Hutson TE, Margolin K, Harmon CS, DePrimo SE, Kim ST, Chen I, George DJ
(2008) J Clin Oncol 26: 3743-8
MeSH Terms: Administration, Oral, Adult, Aged, Angiogenesis Inhibitors, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Bevacizumab, Biomarkers, Tumor, Carcinoma, Renal Cell, Disease-Free Survival, Drug Administration Schedule, Drug Resistance, Neoplasm, Female, Humans, Indoles, Kidney Neoplasms, Male, Middle Aged, Placenta Growth Factor, Pregnancy Proteins, Prospective Studies, Pyrroles, Sunitinib, Time Factors, Treatment Failure, United States, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor C, Vascular Endothelial Growth Factor Receptor-3
Added March 20, 2014
0 Communities
1 Members
0 Resources
29 MeSH Terms